Communicable Diseases Act, B.E. 2558 (2015) · dangerous communicable disease

Notification of the Ministry of Public Health Re: The names and presenting symptoms of dangerous communicable diseases (No.4), B.E. 2567 (2024)

Published in the Government Gazette 9 May B.E. 2567 (2024); in force from 10 May B.E. 2567 (2024)

Whereas it is expedient to amend the presenting symptoms of the dangerous communicable disease “Extensively drug-resistant tuberculosis (XDR-TB)” for the purpose of surveillance, prevention, and control of dangerous communicable diseases in accordance with the Communicable Diseases Act, B.E. 2558 (2015);

By virtue of section 5 and section 6 (1) of the Communicable Diseases Act, B.E. 2558 (2015), the Minister of Public Health by and with the advice of the National Communicable Disease Committee, hereby issues the following Notification:

Clause 1. This Notification is called “Notification of the Ministry of Public Health Re: the names and presenting symptoms of dangerous communicable diseases (No.4), B.E. 2567 (2024)”

Clause 2. This Notification shall come into force on the day following the date of its publication in the Government Gazette.

Clause 3. The provision under (13) of Clause 1 of the Notification of the Ministry of Public Health Re: the and presenting symptoms of dangerous communicable diseases, B.E. 2559 (2016), as amended by the Notification of the Ministry of Public Health Re: the names and presenting symptoms of dangerous communicable diseases (No.2), B.E. 2561 (2018), shall be repealed and replaced with the following:

“(13) Extensively Drug-Resistant Tuberculosis (XDR-TB) as follows:

(a) In the case of extensively drug-resistant tuberculosis, which means tuberculosis that is resistant to four categories of anti-tuberculosis drugs, namely: Isoniazid, Rifampicin, Fluoroquinolones, and second-line injectable drugs. Symptoms may include a chronic cough or hemoptysis, loss of appetite, weight loss, fatigue, fever, chest pain, and shortness of breath. The disease is transmissible to others. In severe cases, respiratory failure may occur, which may result in death.

(b) In the case of extensively drug-resistant tuberculosis, which means tuberculosis that is resistant to multiple anti-tuberculosis drugs, including Rifampicin, with or without resistance to Isoniazid, and resistant to Fluoroquinolones, namely: Levofloxacin or Moxifloxacin (at least one), and resistant to either Bedaquiline or Linezolid (at least one), Symptoms may include a chronic cough or hemoptysis, loss of appetite, weight loss, fatigue, fever, chest pain, shortness of breath, or symptoms related to the infected organ. The disease is transmissible to others. In severe cases, respiratory failure may occur, which may result in death.”

Announced on the 27th Day of March B.E. 2567 (2024)

Chonlanan Srikaew

Minister of Public Health

Unofficial English translation by the Division of Legal Affairs, Department of Disease Control (August 2025), book page 57; the Thai text prevails.